Cipla is a global pharmaceutical company, which offers active pharmaceutical ingredients and formulations in various therapeutic areas, such as women’s health, cardiovascular, children’s health, dermatology and cosmeceuticals, diabetes, HIV-AIDS, hepatitis, oncology, infectious diseases and critical care, malaria, neurosciences, ophthalmology, osteoporosis, respiratory, and urology. The Company also provides veterinary products, including anti-infectives, anti-inflammatories, anti-thyroids, immunosuppressants, parasiticides, nutraceuticals, and feed additives for various animals.

Mumbai, IN
Size (employees)
23,043 (est)
Cipla was founded in 1935 and is headquartered in Mumbai, IN
Report incorrect company information

Key People/Management at Cipla

Umang Vohra

Umang Vohra

Kedar Upadhye

Kedar Upadhye

Global CFO
Ranjana Pathak

Ranjana Pathak

Global Head - Quality
Geena Malhotra

Geena Malhotra

Global Head - Integrated Product Development
Prabir Jha

Prabir Jha

President & Global CPO
Raju Subramanyam

Raju Subramanyam

Global Head - Operations

Cipla Office Locations

Cipla has offices in South Melbourne, Central Islip, Sunrise, Windhoek and in 6 other locations
Mumbai, IN (HQ)
Ganpatrao Kadam Marg
Hyderabad, IN
Karvy Selenium Tower B, Plot No.: 31 & 32 Gachibowli
South Melbourne, AU
1 132-136 Albert Rd
Windhoek, NA
12 Gold Street, Office No C12 Warehouse 1
Cape Town, ZA
9 Mispel Street
East London, ZA
14 Stewart Dr
Show all (10)
Report incorrect company information

Cipla News and Updates

Global Peptides Market Report 2018: By Product, Application, Manufacturer, Sales and Segmentation – Global QYResearch

"Global Peptides Market Professional Survey Report 2018" is the latest addition to Global QYResearch industry research reports collection. Posted via Industry Today. Follow us on Twitter @IndustryToday

Global Malaria Drugs Market 2018 Key Players: Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche. adds “Malaria Drugs Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2025”reports to its database. Posted via Industry Today. Follow us on Twitter @IndustryToday

Asia Pacific Alopecia Treatment Market to Raise at a CAGR of 6.6% by 2024

Growth of the alopecia treatment market is mainly driven by increasing demand for hair loss treatment drugs with enhanced effectiveness and minimal side effects. Posted via Industry Today. Follow us on Twitter @IndustryToday

Respiratory Inhaler Devices Market Projected to Reach US$ 44 Bn in 2027: FMI

Future Market Insights has announced the addition of the “Respiratory Inhaler Devices Market: Global Industry Analysis and Opportunity Assessment 2017-2027" report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday

Smoking Cessation and Nicotine De-Addiction Products Market to Surpass US$ 46.0 Billion by 2024

Global Smoking Cessation and Nicotine De-addiction Products Market, By Product Type, Distribution Channel, Geography - Trends, Analysis, and Forecast till 2024 Posted via Industry Today. Follow us on Twitter @IndustryToday

World Menopause Treatment Market US $ 3.3 Billion Expects Significant Gains by 2023

The Global Menopause Treatment Market has been segmented on the basis of hormonal treatment, non-hormonal treatment and end user. Based on the hormonal treatment, the market has been segmented as estrogen, progesterone, combination of the two and other. Posted via Industry Today. Follow us on Twitt…
Show more
Report incorrect company information